
Welcome from the NATA Chair and Keynote Speech
25 Years of Leadership: Shaping the Future of Patient Blood Management, Thrombosis & Haemostasis
Jens Meier, Linz, Austria
25 Years of Leadership: Shaping the Future of Patient Blood Management, Thrombosis & Haemostasis
Jens Meier, Linz, Austria
Chairs: Sigismond Lasocki | Elvira Bisbe
Treating ID in heart failure patients
Treating ID to improve recovery
Treating ID to avoid infection
Intravenous iron administration at home?
Chairs: Thorsten Haas | Marc Samama
PPH
Trauma
Cardiac Surgery
Liver Surgery
Chairs: Toby Richards | Maria Beatrice Rondinelli
Heavy menstrual bleeding (diagnosis and treatment)
Peripartum anaemia
PPH treatment
Chairs: Jens Meier | Alexander Vlaar
1. In myocardial infarction
2. In brain injury patients
Chairs: Patrick Meybohm | Diana Paupero-Castro
What are the new technologies?
Shall I use it in cancer patients?
Is it worth the cost?
Chairs: Ravishankar Raobaikady | Marc Samama
Reversal of direct oral anticoagulants: guidance from ISTH
Factor XIII !
New antifibrinolytics
Chairs: Sigismond Lasocki | Patrick Meybohm
Training our future leaders: What anesthesiologists and critical care physicians should know about transfusion medicine
Patient blood management is the future of acute care and patient recovery
Moving the needle in cardiac surgical procedures
Chairs: Aurora Espinosa | Alexander Vlaar
We need blood
We need factors!
No too much plasma
Chairs: Maria Beatrice Rondinelli | Tina Tomić Mahečić
VitB12 and folate are important!
Functional iron deficiency
Anaemia in cancer
Chairs: Aurora Espinosa | Vernon Louw
Ethan CRISPELL
Sheharyar RAZA
Beth MACLEAN
Chairs: Jens Meier | Thorsten Haas
Why is haemoglobin important?
Why microcirculation is important and how to measure it
How can I do in clinical practice?
Chairs: Andrea Steinbicker | Elvira Bisbe
PBM in the digital age: optimising outcomes through innovative approaches
Machine Learning and PBM
Data science: the next revolution in patient blood management
Hot topics session
Chairs: Toby Richards | Vernon Louw
Closing Session
Chairs: Sigismond Lasocki | Patrick Meybohm
Lorem ipsum odor amet, consectetuer adipiscing elit. Dictum ipsum per platea taciti libero sapien ullamcorper et purus. Lectus inceptos ligula nibh quisque luctus maximus. Nascetur primis diam massa ut elit
Despite studies supporting a restrictive red cell transfusion strategy in many medical situations, a more liberal strategy is still widely used in patients who need extracorporeal membrane oxygenation (ECMO), Alexander
Anticoagulation treatment has been revolutionised in the past few decades with the development of drugs that increasingly target individual components of the coagulation cascade. Yet the quest to find improved
Tranexamic acid (TXA) is safe to use to prevent bleeding in patients at the time of surgery, even in those at risk of thrombosis, according to Patrick Meybohm (University Hospital